1 – 41 of 41
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Targeting of bone morphogenetic protein complexes to heparin/heparan sulfate glycosaminoglycans in bioactive conformation
(
- Contribution to journal › Article
- 2022
-
Mark
Pretreatment with heparin in patients with ST-segment elevation myocardial infarction : a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)
(
- Contribution to journal › Article
- 2021
-
Mark
Bivalirudin Versus Heparin Monotherapy in ST-Segment-Elevation Myocardial Infarction
(
- Contribution to journal › Article
-
Mark
Heparin fragments induce cervical inflammation by recruiting immune cells through Toll-like receptor 4 in nonpregnant mice
(
- Contribution to journal › Article
-
Mark
Binding of the human antioxidation protein α1-microglobulin (A1M) to heparin and heparan sulfate. Mapping of binding site, molecular and functional characterization, and co-localization in vivo and in vitro
(
- Contribution to journal › Article
- 2020
-
Mark
Relationship between degree of heparin anticoagulation and clinical outcome in patients receiving potent P2Y12-inhibitors with no planned glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention in acute myocardial infarction : a VALIDATE-SWEDEHEART substudy
(
- Contribution to journal › Article
-
Mark
Bivalirudin Versus Heparin Monotherapy in Elderly Patients With Myocardial Infarction : A Prespecified Subgroup Analysis of the VALIDATE-SWEDEHEART Trial
(
- Contribution to journal › Article
- 2018
-
Mark
Pretreatment with ticagrelor may offset additional inhibition of platelet and coagulation activation with bivalirudin compared to heparin during primary percutaneous coronary intervention
(
- Contribution to journal › Article
- 2017
-
Mark
Vitronectin
2017) p.351-360(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2015
-
Mark
Improving outcomes in patients with coronary heart disease using national registers and platelet function testing
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Does Low-Molecular-Weight Heparin Influence the Antimyeloma Effects of Thalidomide? A Retrospective Analysis of Data from the GIMEMA, Nordic and Turkish Myeloma Study Groups
(
- Contribution to journal › Article
- 2013
-
Mark
Heparin does not improve graft function in uncontrolled non-heart-beating lung donation: an experimental study in pigs
(
- Contribution to journal › Article
- 2012
-
Mark
A randomized study of coronary artery bypass surgery performed with the Resting Heart™ System utilizing a low vs a standard dosage of heparin.
(
- Contribution to journal › Article
- 2011
-
Mark
A novel treatment approach for paediatric Gorham-Stout syndrome with chylothorax
(
- Contribution to journal › Article
- 2010
-
Mark
Discarding Heparins as Treatment for Progressive Stroke in Sweden 2001 to 2008
(
- Contribution to journal › Article
- 2009
-
Mark
Determination of dissociation constants between polyelectrolytes and proteins by affinity capillary electrophoresis
(
- Contribution to journal › Article
- 2008
-
Mark
Recombinant human factor VIIa and a factor VIIa-analogue reduces heparin and low molecular weight heparin (LMWH)-induced bleeding in rats
(
- Contribution to journal › Article
-
Mark
Efficacy and safety of anticoagulant prophylaxis to prevent venous thromboembolism in acutely ill medical inpatients: a meta-analysis
(
- Contribution to journal › Article
- 2007
-
Mark
Beneficial effects of dalteparin on haemostatic function and local tissue oxygenation in patients with diabetes, severe vascular disease and foot ulcers
(
- Contribution to journal › Article
-
Mark
Thromboprophylaxis with dalteparin in medical patients: which patients benefit?
(
- Contribution to journal › Article
-
Mark
Antimicrobial peptides derived from growth factors
(
- Contribution to journal › Article
- 2006
-
Mark
Bacterial killing by heparin-binding peptides from PRELP and thrombospondin
(
- Contribution to journal › Article
- 2005
-
Mark
Synthesis, Function, and Inactivation of Blood Coagulation Factor V.
(
- Thesis › Doctoral thesis (monograph)
- 2004
-
Mark
Heparin protects against skin flap necrosis: relationship to neutrophil recruitment and anti-coagulant activity
(
- Contribution to journal › Article
-
Mark
Altered inactivation pathway of factor Va by activated protein C in the presence of heparin
(
- Contribution to journal › Article
-
Mark
Mode of binding of fibrinogen, fibronectin and iron-binding proteins by animal enterococci
(
- Contribution to journal › Article
-
Mark
Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients
(
- Contribution to journal › Article
-
Mark
Serology of human papillomavirus type 16
2004)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Antithrombotic Effects of Activated Protein C and Heparins in Deep Arterial Injury
2004)(
- Thesis › Doctoral thesis (compilation)
- 2002
-
Mark
Binding of extracellular matrix molecules by staphylococci from wild herbivores
(
- Contribution to journal › Article
-
Mark
Helicobacter pylori cell surface interactions with glycosaminoglycans. Identification and characterisation of proteins binding to heparin/heparan sulphate.
2002)(
- Thesis › Doctoral thesis (compilation)
- 2000
-
Mark
Interactions between staphylococci, heparin, heparin dependent growth factors and biomaterials
2000)(
- Thesis › Doctoral thesis (compilation)
- 1999
-
Mark
Structure and Interactions of the Extracellular Matrix Protein PRELP
1999)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Teneurin-1, a vertebrate homologue of the Drosophila pair-rule gene ten-m, is a neuronal protein with a novel type of heparin-binding domain
(
- Contribution to journal › Article
- 1998
-
Mark
Hemodilution with dextran: Effects on blood flow and thrombus formation. An experimental study in the rabbit
1998)(
- Thesis › Doctoral thesis (compilation)
- 1995
-
Mark
Homozygous APC-resistance combined with inherited type I protein S deficiency in a young boy with severe thrombotic disease
(
- Contribution to journal › Article
- 1993
-
Mark
Tissue factor pathway inhibitor (TFPI) and its response to heparin in patients with spontaneous deep vein thrombosis
(
- Contribution to journal › Article
- 1991
-
Mark
Pharmacokinetics of a low molecular weight heparin, logiparin, after intravenous and subcutaneous administration to healthy volunteers
(
- Contribution to journal › Article
-
Mark
Proliferation of cultured fibroblasts is inhibited by L-iduronate-containing glycosaminoglycans
(
- Contribution to journal › Article
- 1990
-
Mark
Plasma lipolytic activity and substrate oxidation after intravenous administration of heparin and a low molecular weight heparin fragment
(
- Contribution to journal › Article
- 1987
-
Mark
Plasma lipolytic activity after subcutaneous administration of heparin and a low molecular weight heparin fragment
(
- Contribution to journal › Article